✈️ Download our latest Travel Playbook here. Unravelling the complexities of the travel industry in a globalised world. 🗺️

ECB April Meeting Preview: Biding time until June meeting

  • Go back to blog home
  • All posts
    All posts|Currency Updates
    All posts|Currency Updates|International Trade
    All posts|International Trade
    Blog
    Central Bank Meetings
    Charities & NGOs
    Currency Updates
    Currency Updates|In The News
    Ecommerce
    Fraud
    FX 101
    In The News
    International Trade
    Podcast
    Press Release
    Product Update
    Security & Fraud
    Special FX Reports
    Special Report
    Weekly Market Update
  • Latest

21 April 2021

Written by
Matthew Ryan

Matthew Ryan is Ebury’s Global Head of Market Strategy, based in London, where he has been part of the strategy team since 2014. He provides fundamental FX analysis for a wide range of G10 and emerging market currencies.

This Thursday’s meeting of the European Central Bank is expected to be uneventful for the FX market, but will be closely watched by investors nonetheless.

I
n March, the ECB stepped up efforts to rein in rising European bond yields and support the economic rebound in the common bloc. The bank announced that it would be front-loading the pace of purchases under its emergency pandemic asset purchase programme (PEPP) in order to prevent a ‘tightening of financing conditions that is inconsistent with countering the downward impact of the pandemic on the projected path of inflation.’

Since the March meeting, macroeconomic data out of the Euro Area has been largely resilient (Figure 1). The business activity PMIs have ticked higher, retail sales grew more than expected in February and the monthly sentiment indices have generally surprised to the upside. There is also now broad optimism about the bloc’s vaccination programme, which is expected to pick-up pace significantly in the second quarter of the year following an inauspicious start. Around 400 million vaccine doses are now expected to be made available in the EU the second quarter of the year after less than 80 million were administered in Q1.

Figure 1: Key Macroeconomic Data Releases [Euro Area] (since 11/03/2021)

Source: Refinitiv Datastream Date: 20/04/2021

That being said, there remain a handful of reasons why we may see a modestly dovish tilt in this Thursday’s communications. New virus cases have risen in the Euro Area during the third wave of infection and many nations in the bloc, notably Germany and France, have either extended lockdown measures or reimposed tougher virus restrictions. It remains likely that the majority of Europe won’t be in a position to significantly unwind lockdown measures until a few months down the road, thus delaying the economic recovery. With this in mind, we expect President Lagarde to state that the outlook of the bloc’s economy remains ‘broadly balanced’. We also think that the Governing Council will reiterate its commitment to maintaining a greater pace of asset purchases in Q2, and see little risk of a return to the previous 60 billion euros a month level until either the June or September meetings.

Regarding the future of the PEPP, we think that it is far too early for the bank to begin discussing policy normalisation. The programme is currently set to run until March 2022, but we are unlikely to see any change in forward guidance until later in the year. At this point the bank will have a much clearer idea as to the state of the health crisis and, in particular, its impact on Euro Area inflation, which continues to print well short of both the bank’s long-term target and its near-term expectations (Figure 2).

Figure 2: Euro Area Inflation Rate (2013 – 2021)

Source: Refinitiv Datastream Date: 20/04/2021

Overall, we think that the market reaction to this week’s ECB meeting may be muted and we don’t expect any sweeping changes to the bank’s recent rhetoric. More upbeat communications about growing vaccine optimism may, however, further support the euro’s recent rally that has seen it surge back above the psychological 1.20 level versus the US dollar.

SHARE